Patients With Long COVID Symptoms Demonstrate Elevated Levels Of Inflammatory Molecules, Research Finds

Healio (7/5, Volansky) reported research found “patients with long COVID symptoms demonstrate elevated levels of several inflammatory molecules – findings that could have important implications in both rheumatology and the search for a potential treatment for long COVID.” The findings “showed a correlation between long COVID and elevated markers of myeloid inflammation and complement activation.” Meanwhile, “patients with cardiorespiratory symptoms, fatigue and anxiety or depression reported higher levels of IL-1R2, MATN2 and COLEC12, while MATN2, CSF3 and C1QA were observed among patients experiencing gastrointestinal symptoms.” The findings were published in Nature Immunology.